Synovial Sarcoma – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030

Synovial Sarcoma (SS) is a soft tissue sarcoma that mimics a benign neoplasm due to its slow growth and distal predisposition. A slow-growing mass, compression symptoms, or irritation to nearby structures are all common symptoms of SS. These cancers are well-known for their proclivity for being misdiagnosed. They've been said to look like arthritis, synovitis, bursitis, hemangiomas, and hematomas, especially when small calcifications accompany them. SS affects specific areas, with 60 percent to 70 percent of cases affecting the lower extremity, and is frequently associated with bursae, tendon sheaths, and joint capsules. Monophasic and biphasic SS are the two major subtypes of SS histologically. Monophasic tumors, found in all three of our patients, are made up of spindled cells and have a better prognosis. They usually present as smaller masses with no metastases. The incidence of Synovial Sarcoma (SS) varies from 3.2 to 4.65 cases per million populations in the USA. The competi...